Inicio › Sobrepeso › California
Ensayos clínicos de Sobrepeso en California
69 estudios sobre Sobrepeso buscan participantes en California.
Ciudades en California
- Los Angeles18 estudios
- Concord15 estudios
- San Diego14 estudios
- Escondido11 estudios
- Torrance8 estudios
- Tustin8 estudios
- Santa Ana8 estudios
- El Cajon8 estudios
- Sacramento6 estudios
- Westminster5 estudios
- Huntington Beach5 estudios
- Long Beach5 estudios
- Santa Monica5 estudios
- Indio5 estudios
- Chula Vista4 estudios
- Riverside4 estudios
- Hawthorne4 estudios
- South Gate4 estudios
- Glendale4 estudios
- Richmond4 estudios
- Santa Clarita4 estudios
- Simi Valley4 estudios
- Modesto3 estudios
- Lake Forest3 estudios
- Ontario3 estudios
- Irvine3 estudios
- Anaheim3 estudios
Texto oficial del estudio (inglés)
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Apex Clinical Research, San Diego
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07871409A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- University of California Irvine, Irvine
- Artemis Institute for Clinical Research, LLC, San Diego
- Diablo Clinical Research, Inc., Walnut Creek
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351045A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Escondido
- Research Site, Lincoln
- Research Site, Walnut Creek
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- University of California Irvine, Irvine
- Orange County Research Center, Lake Forest
- Ark Clinical Research, Long Beach
- y 4 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351058Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Diablo Clinical Research - Flourish Research, Walnut Creek
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07685808Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Peninsula Research Associates, Chula Vista
- Desert Oasis Healthcare Medical Group, Palm Springs
- Inland Empire Liver Foundation, Rialto
- y 2 más
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07575399A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity
- Anaheim Clinical Trials, LLC, Anaheim
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07876531A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Probe Clinical Research Corporation, Riverside
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07823608A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Velocity Clinical Research - Los Angeles, Los Angeles
- Headlands Research Sacramento, Sacramento
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07845500Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Acclaim Clinical Research, San Diego
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07866066A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
- Institute for Metabolic Research Los Angeles, Los Angeles
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07843485A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Headlands Research California, LLC, Escondido
- Prospective Research Innovations Inc., Rancho Cucamonga
- Solace Clinical Research, Tustin
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07919678A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Orange County Research Center, Lake Forest
- Healthy Brain Clinic, Long Beach
- Los Angeles Institute for Metabolic Research, Los Angeles
- y 6 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- y 4 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Pacific Clinical Studies Inc., Los Alamitos
- Los Angeles Institute for Metabolic Research, Los Angeles
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- First OC Dermatology Research Inc, Fountain Valley
- Center For Dermatology Clinical Research, Inc., Fremont
- Metropolis Dermatology, Los Angeles
- y 1 más
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06857942A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- San Fernando Valley Health Institute, Canoga Park
- AMCR Institute, Escondido
- NorCal Medical Research, Inc, Greenbrae
- y 6 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Irvine Clinical Research, Irvine
- Scripps Whittier Diabetes Institute, La Jolla
- EndoTrials Center for Clinical Research, La Mesa
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Wolverine Clinical Trials, Santa Ana
- Encompass Clinical Research, Spring Valley
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- y 1 más
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Ark Clinical Research, Long Beach
- Collaborative Neuroscience Research, LLC, Los Alamitos
- Artemis Institute for Clinical Research, Riverside
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- y 1 más
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication
- UCLA Center for Human Nutrition, Los Angeles
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07806838A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Loma Linda University School of Medicine, Loma Linda
- Childrens Hospital of Los Angeles, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
- y 2 más
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06672549A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Wolverine Clinical Trials, Santa Ana
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06897475An Open Label Pilot Study Assessing the Impact of Chromium Picolinate Supplementation on Appetite and Cravings in Overweight Individuals
- People Science, Los Angeles
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 35 a 70 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07909109Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
- Catalina Research Institute LLC (CRI) - Montclair, Montclair
ReclutandoFase 1
Edades de 18 a 70 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07908316A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Escondido
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07784725A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Bakersfield
- Research Site, Gardena
- Research Site, Lincoln
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07784270Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- John Muir Health - Concord /ID# 282469, Concord
- Aurora FDRC Inc. /ID# 282494, Costa Mesa
- NorCal Medical Research /ID# 283117, Greenbrae
- y 7 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07752979Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
- Exponent Menlo Park, Menlo Park
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT07776678Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Profound Research, Oceanside
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 26 oct 2026 · NCT07837973A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Escondido
- ACCOMPLISH-2 Research Site, Fountain Valley
- ACCOMPLISH-2 Research Site, La Jolla
- y 4 más
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 a 79 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07654374Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Diablo Clinical Research, Inc., Walnut Creek
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT07607587A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication
- PAREXEL Glendale/LA EPCU, Glendale
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT07868354A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication
- PAREXEL Glendale/LA EPCU, Glendale
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT07855133A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- NorCal Medical Research, Inc, Greenbrae
- Velocity Clinical Research, Huntington Park, Huntington Park
- Peninsula Research Associates, Rolling Hills Estates
- y 1 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07589608A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- NorCal Medical Research, Inc, Greenbrae
- Velocity Clinical Research, Huntington Park, Huntington Park
- Peninsula Research Associates, Rolling Hills Estates
- y 1 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 7 oct 2026 · NCT06143956A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
- Institute for Metabolic Research Los Angeles, Los Angeles
ReclutandoFase 3
Edades de 40 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT07843472Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Ark Clinical Research- Tustin, Fountain Valley
- Long Beach Clinical Trials Services Inc, Long Beach
- Ark Clinical Research- Long Beach, Long Beach
- y 6 más
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07684235De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.